1.
Bos V, Crouwel F, Waaijenberg P, Bouma G, Duijvestein M, Buiter H, Brand H, Hamer H, de Boer N. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease. JGLD [Internet]. 15Sep.2022 [cited 28Jan.2023];31(3):283-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/4215